NYSE:LLY News 22 October 2025

Netflix’s 10-for-1 Stock Split Arrives Monday: What NFLX Investors Need to Know Today – and Why Eli Lilly Could Be Next

Netflix’s long-awaited 10‑for‑1 stock split is now entering its crucial final stage. After today’s market close, existing shareholders will receive nine additional shares for every one they already own, with split‑adjusted trading set to begin on Monday, November 17. Netflix+2Nasdaq+2

14 November 2025

Novo Nordisk (NVO) Slashes Wegovy Price in India Up to 37% as Board Vote Nears; U.S. Access Deal Sets 2026 Shift — Nov. 11, 2025

Novo Nordisk cuts Wegovy prices in India up to 37% and faces a pivotal board vote this week, as a U.S. pricing/access deal looms for 2026. Date: November 11, 2025 Key takeaways India: Wegovy gets markedly cheaper — and it’s

11 November 2025

Business News · Drug Pricing · Healthcare Industry · India Market · NYSE:LLY · NYSE:NVO · Pharmaceuticals

Eli Lilly (LLY) Pops on Fresh Deal Spree: MeiraGTx Gene Therapy Tie‑Up, New AI Collaboration, and Leerink Upgrade — Nov. 10, 2025

Eli Lilly and Company (NYSE: LLY) opened the week with a burst of dealmaking and Wall Street momentum. The pharma giant announced a rights deal for a pediatric blindness gene therapy from MeiraGTx, unveiled a new AI‑driven discovery partnership, and

10 November 2025

Artificial Intelligence · Biotech News · Gene Therapy · NASDAQ:ADVM · NASDAQ:MGTX · NASDAQ:NVDA · NYSE:LLY · Pharmaceuticals · Stock Market

Novo Nordisk (NVO) Stock Tanks as Weight-Loss Empire Faces Boardroom Coup and Fierce Rivalry

NVO Stock Today (Nov 6, 2025): Novo Nordisk volatile as White House pricing deal reshapes GLP‑1 market—what it means for Wegovy, Ozempic and investors

Published: November 6, 2025 TL;DR: Novo Nordisk’s U.S.‑listed shares (NYSE: NVO) swung after the White House announced a pricing-and-access deal with Novo and Eli Lilly that expands Medicare coverage for anti‑obesity drugs and cuts out‑of‑pocket costs. As of 17:51 UTC

6 November 2025

GLP‑1 Drugs · Healthcare Policy · Investment Analysis · NYSE:LLY · NYSE:NVO · Pharmaceuticals · Stock Market

Big Pharma’s Billion-Dollar Bet: Inside Eli Lilly’s $5B Virginia Factory and America’s New Drug Manufacturing Boom

Eli Lilly (LLY) Pops as White House Strikes Obesity-Drug Pricing Deal; New 20% Weight‑Loss Data Fuels Momentum — Today, November 6, 2025

Eli Lilly stock today: drivers, numbers, and what to watch for next. Key takeaways (Nov 6, 2025) Eli Lilly stock today: quote & range As of this afternoon, LLY traded near $935.89, up about 1.1%, with today’s range $916.37–$949.90 and

6 November 2025

Drug Pricing · Healthcare · NYSE:LLY · NYSE:NVO · Obesity · Pharmaceuticals · Weight Loss

Eli Lilly Stock Pre-Market Preview: Will Obesity-Drug Boom Send LLY to New Highs? (Nov 3, 2025)

Market Snapshot (pre-market Nov 3) As of Oct. 31 close, Eli Lilly (NYSE:LLY) was around $862–864 (with after-hours ~864) stockanalysis.com marketbeat.com. That’s up ~9–10% from early October nasdaq.com. Trading volumes have been heavy, and LLY remains near its 52-week high

2 November 2025

Eli Lilly · Health Industry · NYSE:LLY · Pharmaceuticals · Pre-Market · Stock Forecast

Eli Lilly (LLY) Stock Soars on Weight-Loss Drug Boom – Can It Hit $1,000?

October Stock Moves and Market Reaction Eli Lilly’s stock has moved sharply in recent weeks. After languishing around the mid-$700s in late September, the stock soared in early October. Between Sept. 29 and Oct. 1 it jumped over 9%, briefly

30 October 2025

Investing · Market Analysis · NYSE:LLY · Pharmaceuticals · Stocks · Weight Loss

Eli Lilly Stock on Fire: GLP-1 Bonanza, Big Earnings & AI Pivot Drive Rally

LLY Stock Snapshot and Recent Moves Eli Lilly’s stock (NYSE: LLY) has been on a tear this year, driven by blockbuster drug sales and upbeat guidance. As of Oct. 29, 2025, LLY traded near $813.53 investing.com. After hitting highs in the

30 October 2025

AI Trends · Earnings Reports · Investment Strategies · NYSE:LLY · Pharmaceuticals · Stock Market

2025’s Best-Performing Stock Market Is Up 35% – Here’s What’s Driving the Rally

Best Stock Market Performance as of October 29, 2025 Global Markets Rally to New Highs Stock markets around the world are on fire heading into the final days of October 2025. Hong Kong’s Hang Seng Index – up about 34–35%

29 October 2025

Economic Analysis · Financial News · Investing · Market Trends · NASDAQ:NVDA · NYSE:JPM · NYSE:LLY · Stock Market

Adverum (ADVM) Stock Skyrockets on News of Lilly’s $12.47/Share Gene Therapy Deal

Sources: Official press releases and filings investors.adverum.com investors.adverum.com, Reuters, Investing.com, Fierce Biotech fiercebiotech.com, and analyst reports marketbeat.com marketbeat.com. All data as of market close Oct. 23, 2025 and news through Oct. 24, 2025.

24 October 2025

Biotech News · Gene Therapy · Investing · Mergers and Acquisitions · NASDAQ:ADVM · NYSE:LLY · Stock Market

Eli Lilly (LLY) Stock Soars on Obesity-Drug Boom — Is $1,000 Next?

Stock Performance and Recent Moves Eli Lilly (NYSE: LLY) has been on a tear in October 2025. After closing around $726 on Sept. 29, the stock surged more than 9% in the following days, briefly spiking to about $832 on

23 October 2025

Financial News · Investing · NYSE:LLY · Obesity Drugs · Pharmaceuticals · Stock Market

Stocks to Buy Today (Oct. 22, 2025): Top Picks as Markets Near Record Highs

Market News & Today’s Financial Outlook Stocks are starting today on cautiously optimistic footing. Futures were little changed this morning after a batch of earnings delivered both relief and warnings. Netflix shocked investors with a rare earnings miss, sending its

22 October 2025

Financial News · Investing · Market Analysis · NASDAQ:AMD · NASDAQ:AMZN · NASDAQ:AVGO · NASDAQ:MSFT · NYSE:BSX · NYSE:FANG · NYSE:LLY · NYSE:ORCL · NYSE:TSM · NYSE:UNH · NYSE:WMT · Stock Market · Top Picks

NYSE:LLY News 22 October 2025 - 14 November 2025